Completion Rate and Side-Effect Profile of Three-Month Isoniazid and Rifapentine Treatment for Latent Tuberculosis Infection in an Urban County Jail | Zendy

María Juarez-Reyes | Zendy; Mark Gallivan | Zendy; Alexander Chyorny | Zendy; Linda M. O’Keeffe | Zendy; Neha Shah | Zendy

Open Access

Completion Rate and Side-Effect Profile of Three-Month Isoniazid and Rifapentine Treatment for Latent Tuberculosis Infection in an Urban County Jail

Author(s) -

María Juarez-Reyes,

Mark Gallivan,

Alexander Chyorny,

Linda M. O’Keeffe,

Neha Shah

Publication year - 2016

Publication title -

open forum infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.546

H-Index - 35

ISSN - 2328-8957

DOI - 10.1093/ofid/ofv220

Subject(s) - rifapentine , medicine , latent tuberculosis , isoniazid , tuberculosis , spec# , pharmacology , mycobacterium tuberculosis , pathology , computer science , programming language

In an urban jail population, 3 months of isoniazid and rifapentine (3HP) was associated with an 85% latent tuberculosis infection treatment completion rate compared with 18% in a standard 9-month isoniazid treatment group. Among the 91 patients who started 3HP therapy, there were 2 treatment discontinuations from adverse drug reactions.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research